Mohamed Hashem1, Ravi Jhaveri2, Doa'a A Saleh3, Sahar A Sharaf4, Fatma El-Mougy4, Lobna Abdelsalam4, Michelle D Shardell5, Hesham El-Ghazaly6, Samer S El-Kamary1. 1. Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore. 2. Division of Infectious Diseases, Department of Pediatrics, University of North Carolina at Chapel Hill School of Medicine. 3. Public Health and Community Medicine. 4. Chemical Pathology, Faculty of Medicine, Cairo University, Egypt. 5. National Institute on Aging, National Institutes of Health, Bethesda, Maryland. 6. Department of Obstetrics and Gynecology Faculty of Medicine, Cairo University, Egypt.
Abstract
BACKGROUND: Postpartum hepatitis C viral (HCV) load decline followed by spontaneous clearance has been previously described. Herein we identify predictors for viral decline in a cohort of HCV-infected postpartum women. METHODS: Pregnant women at Cairo University were screened for anti-HCV antibodies and HCV RNA, and viremic women were tested for quantitative HCV RNA at 3, 6, 9, and 12 months postpartum. Spontaneous clearance was defined as undetectable viremia twice at least 6-months apart. Associations between viral load and demographic, obstetrical, HCV risk factors, and interleukin-28B gene (IL28B) polymorphism (rs12979860) were assessed. RESULTS: Of 2514 women, 97 (3.9%) had anti-HCV antibodies, 54 (2.1%) were viremic and of those, 52 (2.1%) agreed to IL28B testing. From pregnancy until 12 months postpartum, IL28B-CC allele women had a significant viral decline (P = .009). After adjusting, the IL28B-CC allele had a near significant difference compared to the CT allele (odds ratio [OR], 0.75; 95% confidence interval [CI], 0.75,1.00; P = .05), but not the TT allele (OR, 0.91; 95% CI, 0.61,1.38; P = .64). All 14/52 (26.9%) women who subsequently cleared were among the 15 with undetectable viremia at 12 months, making that time point a strong predictor of subsequent clearance (sensitivity = 100%, specificity = 97.4%, positive predictive value = 93.3%, negative predictive value = 100%). CONCLUSIONS: IL28B-CC genotype and 12-month postpartum undetectable viremia were the best predictors for viral decline and subsequent clearance. These 2 predictors should influence clinical decision making.
BACKGROUND: Postpartum hepatitis C viral (HCV) load decline followed by spontaneous clearance has been previously described. Herein we identify predictors for viral decline in a cohort of HCV-infected postpartum women. METHODS: Pregnant women at Cairo University were screened for anti-HCV antibodies and HCV RNA, and viremic women were tested for quantitative HCV RNA at 3, 6, 9, and 12 months postpartum. Spontaneous clearance was defined as undetectable viremia twice at least 6-months apart. Associations between viral load and demographic, obstetrical, HCV risk factors, and interleukin-28B gene (IL28B) polymorphism (rs12979860) were assessed. RESULTS: Of 2514 women, 97 (3.9%) had anti-HCV antibodies, 54 (2.1%) were viremic and of those, 52 (2.1%) agreed to IL28B testing. From pregnancy until 12 months postpartum, IL28B-CC allele women had a significant viral decline (P = .009). After adjusting, the IL28B-CC allele had a near significant difference compared to the CT allele (odds ratio [OR], 0.75; 95% confidence interval [CI], 0.75,1.00; P = .05), but not the TT allele (OR, 0.91; 95% CI, 0.61,1.38; P = .64). All 14/52 (26.9%) women who subsequently cleared were among the 15 with undetectable viremia at 12 months, making that time point a strong predictor of subsequent clearance (sensitivity = 100%, specificity = 97.4%, positive predictive value = 93.3%, negative predictive value = 100%). CONCLUSIONS: IL28B-CC genotype and 12-month postpartum undetectable viremia were the best predictors for viral decline and subsequent clearance. These 2 predictors should influence clinical decision making.
Authors: O Ceci; M Margiotta; F Marello; R Francavilla; P Loizzi; A Francavilla; A Mautone; L Impedovo; E Ierardi; M Mastroianni; S Bettocchi; L Selvaggi Journal: J Pediatr Gastroenterol Nutr Date: 2001-11 Impact factor: 2.839
Authors: Fatma M Shebl; Samer S El-Kamary; Doa'a A Saleh; Mohamed Abdel-Hamid; Nabiel Mikhail; Alif Allam; Hanaa El-Arabi; Ibrahim Elhenawy; Sherif El-Kafrawy; Mai El-Daly; Sahar Selim; Ayman Abd El-Wahab; Mohamed Mostafa; Soraya Sharaf; Mohamed Hashem; Scott Heyward; O Colin Stine; Laurence S Magder; Sonia Stoszek; G Thomas Strickland Journal: J Med Virol Date: 2009-06 Impact factor: 2.327
Authors: Nezam Afdhal; K Rajender Reddy; David R Nelson; Eric Lawitz; Stuart C Gordon; Eugene Schiff; Ronald Nahass; Reem Ghalib; Norman Gitlin; Robert Herring; Jacob Lalezari; Ziad H Younes; Paul J Pockros; Adrian M Di Bisceglie; Sanjeev Arora; G Mani Subramanian; Yanni Zhu; Hadas Dvory-Sobol; Jenny C Yang; Phillip S Pang; William T Symonds; John G McHutchison; Andrew J Muir; Mark Sulkowski; Paul Kwo Journal: N Engl J Med Date: 2014-04-11 Impact factor: 91.245
Authors: David L Thomas; Chloe L Thio; Maureen P Martin; Ying Qi; Dongliang Ge; Colm O'Huigin; Judith Kidd; Kenneth Kidd; Salim I Khakoo; Graeme Alexander; James J Goedert; Gregory D Kirk; Sharyne M Donfield; Hugo R Rosen; Leslie H Tobler; Michael P Busch; John G McHutchison; David B Goldstein; Mary Carrington Journal: Nature Date: 2009-10-08 Impact factor: 49.962
Authors: Samantha L Coss; Almudena Torres-Cornejo; Mona R Prasad; Melissa Moore-Clingenpeel; Arash Grakoui; Georg M Lauer; Christopher M Walker; Jonathan R Honegger Journal: J Clin Invest Date: 2020-02-03 Impact factor: 14.808